175 related articles for article (PubMed ID: 24763891)
1. Topical application of a new monoclonal antibody against fibroblast growth factor 10 (FGF 10) mitigates propranolol-induced psoriasis-like lesions in guinea pigs.
Yao N; Xia JX; Liu XM; Wang N; Mmi XG; Wang YF; Guan LL; Yang J; Dong YY; Wang FW; Li HY; Li XK
Eur Rev Med Pharmacol Sci; 2014; 18(7):1085-91. PubMed ID: 24763891
[TBL] [Abstract][Full Text] [Related]
2. Effect of FGF10 monoclonal antibody on psoriasis-like model in guinea pigs.
Xia JX; Mei XL; Zhu WJ; Li X; Jin XH; Mou Y; Yu K; Wang YY; Li FQ
Int J Clin Exp Pathol; 2014; 7(5):2219-28. PubMed ID: 24966930
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
Goto M; Kadoshima-Yamaoka K; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2010 May; 633(1-3):93-7. PubMed ID: 20132810
[TBL] [Abstract][Full Text] [Related]
4. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes.
Kuang YH; Lu Y; Liu YK; Liao LQ; Zhou XC; Qin QS; Jia XK; Wu LS; Zhu W; Chen X
Eur J Pharmacol; 2018 Apr; 824():57-63. PubMed ID: 29382533
[TBL] [Abstract][Full Text] [Related]
5. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
An J; Li Z; Dong Y; Ren J; Huo J
Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
[TBL] [Abstract][Full Text] [Related]
6. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
7. Albendazole negatively regulates keratinocyte proliferation.
Di Fusco D; Stolfi C; Di Grazia A; Dinallo V; Laudisi F; Marafini I; Colantoni A; Monteleone I; Monteleone G
Clin Sci (Lond); 2020 Apr; 134(7):907-920. PubMed ID: 32236445
[TBL] [Abstract][Full Text] [Related]
8. Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation.
Wen J; Pei H; Wang X; Xie C; Li S; Huang L; Qiu N; Wang W; Cheng X; Chen L
J Dermatol Sci; 2014 Jun; 74(3):242-50. PubMed ID: 24685902
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
10. Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2.
Wei JA; Han L; Lu CJ; Zhao RZ; Sun J; Lu Y; Lin HJ
BMC Complement Altern Med; 2016 Jul; 16():255. PubMed ID: 27473420
[TBL] [Abstract][Full Text] [Related]
11. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
[TBL] [Abstract][Full Text] [Related]
12. Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes.
Ceccarelli S; Cardinali G; Aspite N; Picardo M; Marchese C; Torrisi MR; Mancini P
Exp Cell Res; 2007 May; 313(9):1758-77. PubMed ID: 17449030
[TBL] [Abstract][Full Text] [Related]
13. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor.
Miyoshi K; Takaishi M; Nakajima K; Ikeda M; Kanda T; Tarutani M; Iiyama T; Asao N; DiGiovanni J; Sano S
J Invest Dermatol; 2011 Jan; 131(1):108-17. PubMed ID: 20811392
[TBL] [Abstract][Full Text] [Related]
14. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis.
Kovacs D; Falchi M; Cardinali G; Raffa S; Carducci M; Cota C; Amantea A; Torrisi MR; Picardo M
Exp Dermatol; 2005 Feb; 14(2):130-7. PubMed ID: 15679583
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative and anti-inflammatory effects of 3β,6β,16β-Trihydroxylup-20(29)-ene on cutaneous inflammation.
Horinouchi CD; Mendes DA; Nolte S; Brito PS; Soley BD; Favero GM; Facundo VA; Santos AR; Cabrini DA; Otuki MF
J Ethnopharmacol; 2017 Jan; 195():298-308. PubMed ID: 27880883
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
18. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
[TBL] [Abstract][Full Text] [Related]
20. Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition.
Hayakawa K; Maeda T; Egusa C; Okubo Y; Harada K
Exp Dermatol; 2023 Jun; 32(6):878-888. PubMed ID: 36928929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
